Mettler-Toledo International Inc. (NYSE:MTD) Receives $1,256.25 Consensus Price Target from Brokerages

Shares of Mettler-Toledo International Inc. (NYSE:MTD) have been assigned an average rating of “Hold” from the eight ratings firms that are presently covering the company, Marketbeat Ratings reports. Two equities research analysts have rated the stock with a sell rating, four have given a hold rating and two have assigned a buy rating to the company. The average twelve-month price objective among analysts that have covered the stock in the last year is $1,267.50.

Several equities analysts have recently issued reports on MTD shares. Citigroup lifted their price target on Mettler-Toledo International from $975.00 to $1,200.00 and gave the company a “sell” rating in a research report on Monday, May 13th. Stifel Nicolaus boosted their price target on shares of Mettler-Toledo International from $1,270.00 to $1,510.00 and gave the stock a “buy” rating in a research report on Monday, May 13th. Jefferies Financial Group reissued an “underperform” rating and issued a $1,250.00 price target (up from $1,230.00) on shares of Mettler-Toledo International in a report on Monday, June 3rd. Robert W. Baird lifted their price objective on shares of Mettler-Toledo International from $1,212.00 to $1,360.00 and gave the stock a “neutral” rating in a research note on Monday, May 13th. Finally, Evercore ISI increased their target price on shares of Mettler-Toledo International from $1,375.00 to $1,390.00 and gave the company an “in-line” rating in a research note on Tuesday.

Insider Buying and Selling at Mettler-Toledo International

In other news, CFO Shawn Vadala sold 300 shares of Mettler-Toledo International stock in a transaction on Monday, May 13th. The stock was sold at an average price of $1,457.07, for a total transaction of $437,121.00. Following the transaction, the chief financial officer now owns 4,914 shares in the company, valued at $7,160,041.98. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. In related news, CFO Shawn Vadala sold 300 shares of the firm’s stock in a transaction that occurred on Monday, May 13th. The shares were sold at an average price of $1,457.07, for a total transaction of $437,121.00. Following the completion of the sale, the chief financial officer now directly owns 4,914 shares in the company, valued at $7,160,041.98. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, insider Christian Magloth sold 1,100 shares of the company’s stock in a transaction that occurred on Monday, May 13th. The shares were sold at an average price of $1,470.97, for a total transaction of $1,618,067.00. Following the completion of the transaction, the insider now owns 734 shares in the company, valued at approximately $1,079,691.98. The disclosure for this sale can be found here. Insiders have sold a total of 3,278 shares of company stock valued at $4,871,849 in the last three months. 1.94% of the stock is currently owned by company insiders.

Institutional Trading of Mettler-Toledo International

Hedge funds and other institutional investors have recently modified their holdings of the company. EverSource Wealth Advisors LLC increased its position in Mettler-Toledo International by 8.0% in the 1st quarter. EverSource Wealth Advisors LLC now owns 95 shares of the medical instruments supplier’s stock worth $117,000 after purchasing an additional 7 shares during the last quarter. Gulf International Bank UK Ltd increased its holdings in Mettler-Toledo International by 0.4% in the first quarter. Gulf International Bank UK Ltd now owns 1,813 shares of the medical instruments supplier’s stock worth $2,413,000 after buying an additional 8 shares during the last quarter. Bellevue Group AG raised its position in Mettler-Toledo International by 32.0% during the first quarter. Bellevue Group AG now owns 33 shares of the medical instruments supplier’s stock valued at $44,000 after acquiring an additional 8 shares in the last quarter. Massmutual Trust Co. FSB ADV lifted its stake in Mettler-Toledo International by 7.2% in the second quarter. Massmutual Trust Co. FSB ADV now owns 119 shares of the medical instruments supplier’s stock valued at $166,000 after acquiring an additional 8 shares during the last quarter. Finally, Wealthspire Advisors LLC grew its position in Mettler-Toledo International by 1.2% in the first quarter. Wealthspire Advisors LLC now owns 757 shares of the medical instruments supplier’s stock worth $1,008,000 after acquiring an additional 9 shares in the last quarter. 95.07% of the stock is currently owned by hedge funds and other institutional investors.

Mettler-Toledo International Stock Down 0.2 %

Shares of MTD opened at $1,353.69 on Friday. The firm has a market capitalization of $28.91 billion, a PE ratio of 37.96, a P/E/G ratio of 3.75 and a beta of 1.17. The firm has a 50-day moving average price of $1,405.40 and a 200 day moving average price of $1,296.35. Mettler-Toledo International has a 52-week low of $928.49 and a 52-week high of $1,535.86.

Mettler-Toledo International (NYSE:MTD) last issued its quarterly earnings results on Thursday, May 9th. The medical instruments supplier reported $8.89 earnings per share for the quarter, topping analysts’ consensus estimates of $7.61 by $1.28. Mettler-Toledo International had a net margin of 20.55% and a negative return on equity of 662.32%. The company had revenue of $925.95 million during the quarter, compared to analyst estimates of $879.72 million. During the same period in the prior year, the business posted $8.69 EPS. The business’s revenue for the quarter was down .3% compared to the same quarter last year. On average, equities analysts expect that Mettler-Toledo International will post 40.13 EPS for the current year.

About Mettler-Toledo International

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company's laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.Its industrial instruments comprise industrial weighing instruments and related terminals, automatic dimensional measurement and data capture solutions, vehicle scale systems, industrial software, metal detection equipment, x-ray systems, check weighing equipment, camera-based imaging equipment, track-and-trace solutions, and product inspection systems.